Home    |     Featured Information    |     Sitemap    |    
Share | 
Healthcare Professionals
Patients and Families
Healthcare Professionals
Healthcare Professionals

PML is a rare but serious infection of the central nervous system (CNS). The Progressive Multifocal Leukoencephalopathy (PML) Consortium is a joint effort between Biogen Idec, Bristol-Myers Squibb, Pfizer, MedImmune and Roche intended to enhance the understanding of and identify more effective methods of predicting, preventing and treating PML.

Phase I Grant Proposal Deadline Passed

The deadline for Phase I proposals was February 14th. A new call for grants will be made in Fall 2014. More information

PML Conference ebriefing Posted

A written summary and recordings of select presentations from this year's PML Conference can be viewed at: www.nyas.org/PML2013-eB.